Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (271-280 of 1,111) with videos related to

Pageof 112
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2024
Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD: A Secondary Analysis of the SCORED TrialVikas S Sridhar, Deepak L Bhatt, Ayodele Odutayo, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
American Heart Journal|March 22, 2020
Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trialGuillaume Marquis-Gravel, Zhen Huang, Steven L Zelenkofske, et al.
BMC Ophthalmology|July 6, 2023
Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromesGaspard Suc, Gregory G Schwartz, Shaun G Goodman, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery diseaseIan Ford, Michele Robertson, Nicola Greenlaw, et al.
The American Journal of Cardiology|February 27, 2010
Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)Michel Krempf, Klaus G Parhofer, Ph Gabriel Steg, et al.
Stroke|January 12, 2013
Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosisGaia Sirimarco, Pierre Amarenco, Julien Labreuche, et al.
BMC Ophthalmology|June 16, 2023
Effect of alirocumab on cataracts in patients with acute coronary syndromesGaspard Suc, Gregory G Schwartz, Shaun G Goodman, et al.
Heart (British Cardiac Society)|March 13, 2017
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular riskLouis Potier, Ronan Roussel, Yedid Elbez, et al.
Journal of the American Heart Association|September 30, 2016
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryAlon Eisen, Deepak L Bhatt, P Gabriel Steg, et al.
Pageof 112

Showing results (271-280 of 1,111) with videos related to

Sort By:
Pageof 112
Clinical Journal of the American Society of Nephrology : CJASN|January 26, 2024
Sotagliflozin and Kidney Outcomes, Kidney Function, and Albuminuria in Type 2 Diabetes and CKD: A Secondary Analysis of the SCORED TrialVikas S Sridhar, Deepak L Bhatt, Ayodele Odutayo, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
American Heart Journal|March 22, 2020
Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trialGuillaume Marquis-Gravel, Zhen Huang, Steven L Zelenkofske, et al.
BMC Ophthalmology|July 6, 2023
Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromesGaspard Suc, Gregory G Schwartz, Shaun G Goodman, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery diseaseIan Ford, Michele Robertson, Nicola Greenlaw, et al.
The American Journal of Cardiology|February 27, 2010
Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)Michel Krempf, Klaus G Parhofer, Ph Gabriel Steg, et al.
Stroke|January 12, 2013
Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosisGaia Sirimarco, Pierre Amarenco, Julien Labreuche, et al.
BMC Ophthalmology|June 16, 2023
Effect of alirocumab on cataracts in patients with acute coronary syndromesGaspard Suc, Gregory G Schwartz, Shaun G Goodman, et al.
Heart (British Cardiac Society)|March 13, 2017
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular riskLouis Potier, Ronan Roussel, Yedid Elbez, et al.
Journal of the American Heart Association|September 30, 2016
Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) RegistryAlon Eisen, Deepak L Bhatt, P Gabriel Steg, et al.
Pageof 112